David Chang

High Impact

Research Physician

University of Arkansas for Medical Sciences

faculty

46 h-index 397 pubs 8,818 cited

Research Areas

HIV/AIDS Research and Interventions Microbial infections and disease research Bone health and treatments SARS-CoV-2 and COVID-19 Research Health disparities and outcomes Diet and metabolism studies Orthopedic Surgery and Rehabilitation Pharmacological Effects and Toxicity Studies

Links

ORCID Research Group

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

David Chang's research investigates various aspects of health and disease, with a particular focus on infectious diseases, non-communicable diseases, and bone health. He has published work on the dolutegravir transition in the African Cohort Study, examining weight gain, and has explored the intersection of HIV and SARS-CoV-2, including vaccine research.

His publications also address public health challenges such as pre-exposure prophylaxis implementation gaps in Kenya and non-communicable diseases in people living with and without HIV in African countries. Chang's work extends to specific medical areas, including reducing blood culture contamination and vancomycin use, and investigating poor bone health in Duchenne muscular dystrophy. He also contributes to the literature on waste reduction in orthopedic surgery.

With a substantial publication record (397 total publications) and a high citation count (8,818 total citations), Chang is recognized as a highly cited researcher. He leads a research group and collaborates with other academics, including Zain Alamarat at the University of Arkansas for Medical Sciences.

Metrics

h-index: 46
Publications: 397
Citations: 8,818

Selected Publications

Corrigendum to “Hesitancy and confidence in pediatric COVID-19 vaccination among diverse caregivers of unvaccinated children” [Vaccine 61 (2025) 127245] (2025) DOI
Hesitancy and confidence in pediatric COVID-19 vaccination among diverse caregivers of unvaccinated children (2025) DOI